LPL Financial’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-183,479
| Closed | -$98.8K | – | 5208 |
|
2024
Q4 | $98.8K | Buy |
183,479
+94,623
| +106% | +$51K | ﹤0.01% | 4879 |
|
2024
Q3 | $84.4K | Sell |
88,856
-110,000
| -55% | -$105K | ﹤0.01% | 4819 |
|
2024
Q2 | $194K | Buy |
198,856
+90,000
| +83% | +$87.7K | ﹤0.01% | 4485 |
|
2024
Q1 | $172K | Buy |
+108,856
| New | +$172K | ﹤0.01% | 4469 |
|